Company Filing History:
Years Active: 2015
Title: Gabriele Gadermaier: Innovator in Hypoallergenic Molecules
Introduction
Gabriele Gadermaier is a notable inventor based in Hallwang, Austria. He has made significant contributions to the field of allergen research, particularly through his innovative work on hypoallergenic molecules. His dedication to improving the quality of life for allergy sufferers is evident in his patented inventions.
Latest Patents
Gadermaier holds a patent for hypoallergenic molecules. The invention relates to a hypoallergenic molecule consisting of Bet v Ia or an allergen having at least 40% identity to Bet v Ia. This molecule comprises mutations of at least four amino acid residues in the region of amino acids 100 to 125 of Bet v Ia or its corresponding region of the allergen having at least 40% identity to Bet v Ia. This patent represents a significant advancement in the development of safer allergenic substances.
Career Highlights
Throughout his career, Gadermaier has worked with various organizations, including Biomay AG and Paris-Lodron-Universität Salzburg. His experience in these institutions has allowed him to collaborate with leading experts in the field of allergen research.
Collaborations
Gadermaier has collaborated with notable colleagues such as Michael Wallner and Barbara Bohle. These partnerships have contributed to the advancement of his research and the development of innovative solutions in allergen science.
Conclusion
Gabriele Gadermaier's work in hypoallergenic molecules showcases his commitment to addressing allergy-related challenges. His innovative contributions and collaborations highlight the importance of research in improving health outcomes for individuals with allergies.